Mesenchymal Stem Cells Treatment for Erectile Dysfunction in Diabetic Rats

Area of Science:

• Regenerative Medicine
• Urology
• Endocrinology

Background:

• Aging men with diabetes mellitus (DM) frequently experience erectile dysfunction (ED), often unresponsive to conventional drugs.
• Diabetes mellitus erectile dysfunction (DMED) presents a significant clinical challenge, necessitating alternative therapeutic strategies.

Purpose of the Study:

• To review current research on mesenchymal stem cell treatment (MSCT) for diabetic rat models of ED.
• To evaluate the potential of MSCT as a future treatment for DMED.

Main Methods:

• A literature search was conducted on PubMed using keywords: erectile dysfunction, mesenchymal stem cells, diabetes mellitus, and rat model.
• Representative studies utilizing MSCT in diabetic ED rat models were reviewed.

Main Results:

• Streptozotocin-induced diabetic rats are commonly used models for DMED research.
• Various stem cell types, including bone marrow-derived and adipose-derived mesenchymal stem cells, have been investigated.
• Identified mechanisms of action include improved vascular function, smooth muscle recovery, neuroprotection, reduced inflammation, and decreased apoptosis in the corpus cavernosum.
• Combination therapies (MSCT with drugs, herbs, or shockwave therapy) demonstrated enhanced efficacy.

Conclusions:

• MSCT is an effective and safe treatment for DMED in rat models.
• MSCT represents a promising, minimally invasive therapeutic option for patients with DMED.
• Combining MSCT with other modalities enhances treatment efficiency and addresses MSCT limitations.